课题基金 / 基金详情

AUTOCRINE MECHANISM FOR V-SIS TRANSFORMATION

AUTOCRINE MECHANISM FOR V-SIS TRANSFORMATION
V-SIS 转化的自分泌机制
批准号:
3896380
负责人:
S A AARONSON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

S A AARONSON的其他基金

相关文献

中文摘要
翻译
使用v-sis转化的成纤维细胞系,我们能够证明 α和β血小板衍生生长因子(PDGF)受体 在细胞内的隔间中被激活。然而,表面定位 是将激活的受体偶联到有丝分裂反应所必需的。 这些发现为研究人类肿瘤提供了一个有用的模型系统。 细胞株,并了解PDGF亚型在肿瘤中可能发挥的作用 进程。另外。我们的研究表明,苏拉明这种药物 能完全消除SIS/3T3转化中的转化表型 细胞系。能够显著改变许多人类的扩散 表达α或βPDGF受体的肿瘤细胞株和A 或PDGF的B链。
英文摘要
Using v-sis-transformed fibroblast cell lines, we were able to demonstrate that both alpha and beta platelet-derived growth factor (PDGF) receptors are activated in an intracellular compartment. Yet a surface localization is required for coupling the activated receptors to a mitogenic response. These findings served as a useful model system to investigate human tumor cell lines and understand the role PDGF isoforms may have in the neoplastic process. Additionally. our studies indicate that the drug suramin, which can completely abrogate the transformed phenotype in sis/3T3 transformed cell lines. is able to significantly alter the proliferation of many human tumor cell lines that express either alpha or beta PDGF receptors and the A or B chain of PDGF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STRUCTURAL CHARACTERIZATION OF PUTATIVE GROWTH FACTOR RECEPTOR GENE C-ERB-2
FUNCTIONAL CHARACTERIZATION OF SECRETED FORM OF A VEGF RECEPTOR
TRANSFORMING GENES IN EXPERIMENTAL ONCOGENESIS AND HUMAN CANCER
MITOGENIC SIGNAL TRANSDUCTION IN BALB/MK KERATINOCYTES